scholarly journals Association between Left Ventricular Strain and Health Related Quality of Life and Functional Capacity in Stage A and B Heart Failure

2019 ◽  
Vol 28 ◽  
pp. S238
Author(s):  
K. Haji ◽  
C. Wong ◽  
C. Neil ◽  
T. Marwick
2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
C Proudfoot ◽  
A.F Fonseca ◽  
R Lahoz ◽  
S Corda ◽  
S Cotton ◽  
...  

Abstract Background and purpose Heart Failure (HF) is associated with symptoms such as dyspnoea and fatigue which can impact patients' health related quality of life (HRQoL). This study aimed to characterize and assess the HRQoL of patients with HF and left-ventricular ejection fraction (LVEF) <40% versus those with ≥40%-60%. Methods A cross-sectional study of patients with HF was conducted in France, Germany, Italy, Spain and United Kingdom. Patient record forms (PRFs) were completed by 257 cardiologists and 158 general practitioners (GPs) for consecutively consulting patients. The same patients were invited to provide patient-reported outcomes including self-completion questionnaires, Minnesota Living with Heart Failure Questionnaire (MLHFQ) and EQ-5D-5L VAS. Results 204 HF patients with LVEF <40% (mean age 67.7 years) and 600 patients with LVEF ≥40–60% (mean age 68.9 years) were included. Proportion of males was significantly higher in the lower LVEF group (73.5% vs. 61.2%, p=0.0017). Overall, the patients with lower LVEF more frequently presented with comorbidities than those with LVEF ≥40–60% (p<0.05, Figure 1). NYHA stage III/IV (35.8%/7.4% vs. 15.3%/0.8%) as well as self-reported HF symptoms were more frequently reported in the lower LVEF group (p<0.05, Figure 1). Similarly, patients with LVEF <40% reported statistically significantly worse HRQoL compared to those with LVEF ≥40–60% (Table 1). Conclusions The HRQoL of all HF patients with LVEF ≤60% appears impacted, while those with LVEF <40% had significantly worse HRQoL than those with LVEF ≥40–60%. These differences in HRQoL may not only be related to the LVEF but also to the overall characteristics of these patients. Addressing the HRQoL burden for patients should be a key aspect of HF management strategies for all HF patients. Funding Acknowledgement Type of funding source: Private company. Main funding source(s): Novartis Pharma AG


2004 ◽  
Vol 10 (5) ◽  
pp. 368-373 ◽  
Author(s):  
Frederick A. Masoudi ◽  
John S. Rumsfeld ◽  
Edward P. Havranek ◽  
John A. House ◽  
Eric D. Peterson ◽  
...  

Author(s):  
Mario J. Olivera ◽  
Johana A. Fory ◽  
Giancarlo Buitrago

Chagas disease represents an important cause of heart failure (HF) and affects health-related quality of life (HRQoL). The study aimed to evaluate and compare the HRQoL of patients with chagasic HF and matched non-Chagas controls to identify factors associated with HRQoL. A cross-sectional study with pair-matched controls was conducted in Colombia. From October 2018 to December 2019, a total of 84 HF patients were screened for study subjects. Four were excluded, resulting in 80 patients for the analysis, among whom 40 patients with Chagas were enrolled as cases and 40 gender- and age-matched non-Chagas patients as controls. The Kansas City Cardiomyopathy Questionnaire (KCCQ) and the Minnesota Living with Heart Failure Questionnaire (MLWHFQ) were used to measure HRQoL. Demographic, clinical, and laboratory data were obtained from each subject. Health-related quality of life scores were significantly worse among the Chagas group than among the non-Chagas group in the KCCQ domains of physical functioning and symptoms and in the MLWHFQ scale. In the multivariate analysis, the variables associated with lower HRQoL scores were living alone, obesity, having less than 12 years of education, and an increase in left ventricular diameters in the systole and diastole. Health-related quality of life in patients with chronic HF is impaired across all domains. Chagas patients showed worse HRQoL scores than non-Chagas patients. Six variables, some potentially modifiable, were independently associated with worse HRQoL.


2021 ◽  
Vol 15 (6) ◽  
pp. 1349-1351
Author(s):  
I. Zia ◽  
S. Waqas ◽  
H. M. Asim ◽  
M. Tariq ◽  
A. Shahzad

Aim: To describe health related quality of life using Minnesota Living with Heart Failure Questionnaire (MLWHFQ) in individuals of LVDD post six months. Methods: Descriptive cross sectional survey on 72 individuals of LVDD post six months was conducted. Sample was calculated by WHO sample size calculator keeping μ as 0.49, margin of error as 5% and confidence interval as 95%. Data was collected by MLWHFQ via interview method with Non probability convenience sampling technique from Punjab Institute of Cardiology Lahore and Sheikh Zayed Hospital Lahore during August 2018 to January 2019. Stable individuals both male and female were recruited who aged between 50-71 years old. The baseline characteristic taken in account was NYHA of Heart Failure greater than 2, 50% or more Ejection Fraction, Diastolic Dysfunction (grade ≥1) and at least one of the positive cardiovascular risk factor. Results: Out of a total 72 subjects 41 were males and 31 were females with scores on MLWHFQ showed that out of a total 72 LVDD, HRQOL of 3(4.2%) patients were not affected, 3(4.2%) were very little effected, 7(9.7%) were little effected, 4(5.7%) was moderately effected, 34(47.2%) were much effected and 21(29.2%) were very much effected. Conclusion: The study concluded that health related quality of life using was found out to be much effected in subjects of Left Ventricular diastolic Dysfunction. Keywords: Quality of life, Left Ventricular diastolic dysfunction, Cardiac Disease


2011 ◽  
Vol 17 (9) ◽  
pp. 755-763 ◽  
Author(s):  
Rebecca L. Dekker ◽  
Terry A. Lennie ◽  
Nancy M. Albert ◽  
Mary K. Rayens ◽  
Misook L. Chung ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document